0.6643
-0.0157
(-2.31%)
At close: January 13 at 4:00:02 PM EST
0.6636
-0.00
(-0.11%)
Pre-Market: 4:40:17 AM EST
Breakdown
TTM
7/31/2024
7/31/2023
7/31/2022
7/31/2021
Operating Cash Flow
-21,875.0000
-26,259.0000
-36,976.0000
-16,590.0000
387.0000
Investing Cash Flow
4,261.0000
-545.0000
98,980.0000
25,223.0000
-34,497.0000
Financing Cash Flow
-3,875.0000
-4,193.0000
-1,125.0000
-241.0000
-242.0000
End Cash Position
47,718.0000
52,371.0000
83,373.0000
22,603.0000
14,274.0000
Capital Expenditure
-739.0000
-545.0000
-2,760.0000
-3,472.0000
-4,436.0000
Issuance of Capital Stock
--
--
386.0000
--
--
Issuance of Debt
--
--
23,846.0000
--
--
Repayment of Debt
-3,705.0000
-3,719.0000
-24,982.0000
-269.0000
-339.0000
Free Cash Flow
-22,614.0000
-26,804.0000
-39,736.0000
-20,062.0000
-4,049.0000
7/31/2021 - 6/12/1980
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PRPH ProPhase Labs, Inc.
0.6490
0.00%
PRPO Precipio, Inc.
6.00
-2.91%
NDRA ENDRA Life Sciences Inc.
5.73
-2.63%
STRR Star Equity Holdings, Inc.
2.1900
-0.90%
ICBU iMD Companies, Inc.
0.0025
+4.17%
OCX OncoCyte Corporation
2.0800
-5.88%
ATLN Atlantic International Corp.
4.5500
-11.31%
STIM Neuronetics, Inc.
2.3400
+36.84%
XGN Exagen Inc.
3.1200
-1.58%
APDN Applied DNA Sciences, Inc.
0.1934
-2.18%